Analyze Diet
The Journal of veterinary medical science2024; 86(9); 930-937; doi: 10.1292/jvms.24-0161

Characterization of senescent mesenchymal stem/stromal cells derived from equine bone marrow and the effects of NANOG on the senescent phenotypes.

Abstract: In equine regenerative medicine using bone marrow-derived mesenchymal stem/stromal cells (BM-MSC), the importance of the quality management of BM-MSC has been widely recognized. However, there is little information concerning the relationship between cellular senescence and the stemness in equine BM-MSC. In this study, we showed that stemness markers (NANOG, OCT4, SOX2 and telomerase reverse transcriptase) and colony forming unit-fibroblast apparently decreased accompanied with incidence of senescence-associated β-galactosidase-positive cells by repeated passage. Additionally, we suggested that down-regulation of cell proliferation in senescent BM-MSC was related to increased expression of cyclin-dependent kinase inhibitor 2B (CDKN2B). On the other hand, forced expression of NANOG into senescent BM-MSC brought upregulation of several stemness markers and downregulation of CKDN2B accompanied with restoration of proliferation potential and osteogenic ability. These results suggested that expression of NANOG was important for the maintenance of the stemness in equine BM-MSC.
Publication Date: 2024-07-08 PubMed ID: 38972751PubMed Central: PMC11422694DOI: 10.1292/jvms.24-0161Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Kushida C, Tamura N, Kasashima Y, Sato K, Arai K. (2024). Characterization of senescent mesenchymal stem/stromal cells derived from equine bone marrow and the effects of NANOG on the senescent phenotypes. J Vet Med Sci, 86(9), 930-937. https://doi.org/10.1292/jvms.24-0161

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 86
Issue: 9
Pages: 930-937

Researcher Affiliations

Kushida, Chiho
  • Department of Tissue Physiology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
  • National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Tamura, Norihisa
  • Laboratory of Clinical Science and Pathobiology, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Kasashima, Yoshinori
  • Laboratory of Clinical Science and Pathobiology, Equine Research Institute, Japan Racing Association, Tochigi, Japan.
Sato, Kota
  • National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Tokyo, Japan.
Arai, Katsuhiko
  • Department of Tissue Physiology, Tokyo University of Agriculture and Technology, Tokyo, Japan.

MeSH Terms

  • Animals
  • Mesenchymal Stem Cells / physiology
  • Mesenchymal Stem Cells / cytology
  • Horses
  • Cellular Senescence / physiology
  • Nanog Homeobox Protein / metabolism
  • Nanog Homeobox Protein / genetics
  • Bone Marrow Cells / physiology
  • Bone Marrow Cells / cytology
  • Cell Proliferation
  • Phenotype

Conflict of Interest Statement

The authors declare that they have no competing interests.

References

This article includes 21 references
  1. Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA. 2017. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential ofnWharton’s jelly and bone marrow-derived mesenchymal stem cells. 8: 102. doi: 10.1186/s13287-017-0555-9n
    doi: 10.1186/s13287-017-0555-9pmc: PMC5406919pubmed: 28446235google scholar: lookup
  2. Eto S, Goto M, Soga M, Kaneko Y, Uehara Y, Mizuta H, Era T. 2018. Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeuticnpotentials. 13: e0200790. doi: 10.1371/journal.pone.0200790n
  3. Flores I, Benetti R, Blasco MA. 2006. Telomerase regulation and stem cell behaviour. 18:n254–260. doi: 10.1016/j.ceb.2006.03.003n
    doi: 10.1016/j.ceb.2006.03.003pubmed: 16617011google scholar: lookup
  4. Go MJ, Takenaka C, Ohgushi H. 2008. Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiationncapabilities. 314: 1147–1154. doi: 10.1016/j.yexcr.2007.11.021n
    doi: 10.1016/j.yexcr.2007.11.021pubmed: 18187129google scholar: lookup
  5. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RKW. 2012. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of thensuperficial digital flexor tendon. 44: 25–32. doi: 10.1111/j.2042-3306.2011.00363.xn
  6. Itahana K, Itahana Y, Dimri GP. 2013. Colorimetric detection of senescence-associated β galactosidase. 965: 143–156. doi: 10.1007/978-1-62703-239-1_8n
    doi: 10.1007/978-1-62703-239-1_8pmc: PMC3769963pubmed: 23296655google scholar: lookup
  7. Kasashima Y, Ueno T, Tomita A, Goodship AE, Smith RK. 2011. Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells.n 43: 288–294. doi: 10.1111/j.2042-3306.2010.00215.xn
  8. Liu L, DiGirolamo CM, Navarro PAAS, Blasco MA, Keefe DL. 2004. Telomerase deficiency impairs differentiation of mesenchymal stem cells. 294: 1–8. doi: 10.1016/j.yexcr.2003.10.031n
    doi: 10.1016/j.yexcr.2003.10.031pubmed: 14980495google scholar: lookup
  9. Liu J, Ding Y, Liu Z, Liang X. 2020. Senescence in mesenchymal stem cells: Functional slterations, molecular mechanisms, and rejuvenation strategies.n 8: 258. doi: 10.3389/fcell.2020.00258n
    doi: 10.3389/fcell.2020.00258pmc: PMC7232554pubmed: 32478063google scholar: lookup
  10. Lu H, Lyu Y, Tran L, Lan J, Xie Y, Yang Y, Murugan NL, Wang YJ, Semenza GL. 2021. HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells. 36: 109757. doi: 10.1016/j.celrep.2021.109757n
    doi: 10.1016/j.celrep.2021.109757pubmed: 34592152google scholar: lookup
  11. O’Connor K. 2020. A cautionary tale about the use of colony-forming efficiency as a proxy for the survival of mesenchymal stem cells.n 11: 292. doi: 10.1186/s13287-020-01805-5n
    doi: 10.1186/s13287-020-01805-5pmc: PMC7367266pubmed: 32678014google scholar: lookup
  12. Roche S, Richard MJ, Favrot MC. 2007. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression.n 101: 271–280. doi: 10.1002/jcb.21185n
    doi: 10.1002/jcb.21185pubmed: 17211834google scholar: lookup
  13. Sasao T, Fukuda Y, Yoshida S, Miyabara S, Kasashima Y, Kuwano A, Arai K. 2015. Population doubling level-dependent change of secreted glycosaminoglycan in equine bone marrow-derived mesenchymal stemncells. 26: 73–80. doi: 10.1294/jes.26.73n
    doi: 10.1294/jes.26.73pmc: PMC4591413pubmed: 26435680google scholar: lookup
  14. Shahini A, Mistriotis P, Asmani M, Zhao R, Andreadis ST. 2017. Nanog restores contractility of mesenchymal stem cell-based senescent microtissues. 23: 535–545. doi: 10.1089/ten.tea.2016.0494n
    doi: 10.1089/ten.tea.2016.0494pmc: PMC5467120pubmed: 28125933google scholar: lookup
  15. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SIS, Jensen TG, Kassem M. 2002. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromalncells. 20: 592–596. doi: 10.1038/nbt0602-592n
    doi: 10.1038/nbt0602-592pubmed: 12042863google scholar: lookup
  16. Squillaro T, Severino V, Alessio N, Farina A, Di Bernardo G, Cipollaro M, Peluso G, Chambery A, Galderisi U. 2015. De-regulated expression of the BRG1 chromatin remodeling factor in bone marrow mesenchymal stromal cells induces senescence associated withnthe silencing of NANOG and changes in the levels of chromatin proteins. 14:n1315–1326. doi: 10.4161/15384101.2014.995053n
  17. Tsai CC, Chen CL, Liu HC, Lee YT, Wang HW, Hou LT, Hung SC. 2010. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cellnlines. 17: 64. doi: 10.1186/1423-0127-17-64n
    doi: 10.1186/1423-0127-17-64pmc: PMC2923118pubmed: 20670406google scholar: lookup
  18. Tsai CC, Su PF, Huang YF, Yew TL, Hung SC. 2012. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells.n 47: 169–182. doi: 10.1016/j.molcel.2012.06.020n
    doi: 10.1016/j.molcel.2012.06.020pubmed: 22795133google scholar: lookup
  19. Vidal MA, Walker NJ, Napoli E, Borjesson DL. 2012. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cordntissue. 21: 273–283. doi: 10.1089/scd.2010.0589n
    doi: 10.1089/scd.2010.0589pubmed: 21410356google scholar: lookup
  20. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. 2003. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not.n 121: 368–374. doi: 10.1046/j.1365-2141.2003.04284.xn
  21. Zahedi M, Parham A, Dehghani H, Kazemi Mehrjerdi H. 2018. Equine bone marrow-derived mesenchymal stem cells: optimization of cell density in primary culture. 5: 31. doi: 10.21037/sci.2018.09.01n
    doi: 10.21037/sci.2018.09.01pmc: PMC6232052pubmed: 30498742google scholar: lookup

Citations

This article has been cited 0 times.